[1]
|
Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. The Lancet, 396, 635-648. https://doi.org/10.1016/S0140-6736(20)31288-5
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[3]
|
Bornschein, J., Leja, M., Kupcinskas, J., Link, A., Weaver, J., Rugge, M. and Malfertheiner, P. (2014) Molecular Diagnostics in Gastric Cancer. Frontiers in Bioscience-Landmark, 19, 312-338. https://doi.org/10.2741/4210
|
[4]
|
Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[5]
|
Amin, B.D. and Hoda, S.A. (2012) Minimal Metastic Disease in Sentinal Lymphnodes in Breast Carcinoma: Some Modest Proposalsto Refine Criteria for “Isolate Tumor Cells”. Ad-vances in Anatomic Pathology, 13, 185-189.
https://doi.org/10.1097/00125480-200607000-00005
|
[6]
|
Kogo, R., Mimori, K., Tanaka, F., et al. (2011) Clinical Significance of miR-146a in Gastric Cancer Cases. Clinical Cancer Research, 17, 4277-4284. https://doi.org/10.1158/1078-0432.CCR-10-2866
|
[7]
|
Xuan, W., Yu, H., Zhang, X. and Song, D. (2019) Cross-talk between the lncRNA UCA1 and MicroRNAs in Cancer. FEBS Letters, 593, 1901-1914. https://doi.org/10.1002/1873-3468.13470
|
[8]
|
Ghafouri-Fard, S. and Taheri, M. (2019) UCA1 Long Non-Coding RNA: An Update on Its Roles in Malignant Behavior of Cancers. Biomedicine & Pharmacotherapy, 120, Article ID: 109459.
https://doi.org/10.1016/j.biopha.2019.109459
|
[9]
|
Yao, F., Wang, Q. and Wu, Q. (2019) The Prognostic Value and Mechanisms of lncRNA UCA1 in Human Cancer. Cancer Management and Research, 14, 7685-7696. https://doi.org/10.2147/CMAR.S200436
|
[10]
|
Bae, S., Brumbaugh, J. and Bonavida, B. (2018) Exosomes Derived from Cancerous and Non-Cancerous Cells Regulate the Antitumor Response in the Tumor Microenvironment. Genes & Cancer, 9, 87-100.
https://doi.org/10.18632/genesandcancer.172
|
[11]
|
Thomson, D.W. and Dinger, M.E. (2016) Endogenous MicroRNA Sponges: Evidence and Controversy. Nature Reviews Genetics, 17, 272-283. https://doi.org/10.1038/nrg.2016.20
|
[12]
|
Ghafouri-Fard, S., Shoorei, H., Anamag, F.T. and Taheri, M. (2020) The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells. Frontiers in Oncology, 30, Article ID: 608975.
https://doi.org/10.3389/fonc.2020.608975
|
[13]
|
Cao, Y., Xiong, J.B., Zhang, G.Y., Liu, Y., Jie, Z.G. and Li, Z.R. (2020) Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Pro-gression of Gastric Cancer. Molecular Therapy—Nucleic Acids, 19, 853-864. https://doi.org/10.1016/j.omtn.2019.10.020
|
[14]
|
Gong, P., Qiao, F., Wu, H., Cui, H., Li, Y., Zheng, Y., Zhou, M. and Fan, H. (2018) LncRNA UCA1 Promotes Tumor Metastasis by Inducing miR-203/ZEB2 Axis in Gastric Cancer. Cell Death & Disease, 9, Article No. 1158.
https://doi.org/10.1038/s41419-018-1170-0
|
[15]
|
Lee, B., Hutchinson, R., Wong, H. L., Tie, J., Putoczki, T., Tran, B., et al. (2018) Emerging Biomarkers for Immunomodulatory Cancer Treatment of Upper Gastrointestinal, Pancreatic and Hepatic Cancers. Seminars in Cancer Biology, 52, 241-252. https://doi.org/10.1016/j.semcancer.2017.12.009
|
[16]
|
Bentwich, I., Avniel, A., Karov, Y., et al. (2005) Identifi-cation of Hundreds of Conserved and Nonconserved Human MicroRNAs. Nature Genetics, 37, 766-770. https://doi.org/10.1038/ng1590
|
[17]
|
Bijnsdorp, I.V., Hodzic, J., Lagerweij, T., et al. (2016) miR-129-3p Controls Centrosome Number in Metastatic Prostate Cancer Cells by Repressing CP110. Oncotarget, 7, 16676-16687. https://doi.org/10.18632/oncotarget.7572
|
[18]
|
Link, A., Kupcinskas, J., Wex, T. and Malfertheiner, P. (2012) Macro-Role of MicroRNA in Gastric Cancer. Digestive Diseases, 30, 255-267. https://doi.org/10.1159/000336919
|
[19]
|
Link, A. and Goel, A. (2013) MicroRNA in Gastrointestinal Cancer: A Step Closer to Reality. Advances in Clinical Chemistry, 62, 221-268. https://doi.org/10.1016/B978-0-12-800096-0.00006-8
|
[20]
|
Lujambio, A. and Lowe, S.W. (2012) The Microcosmos of Cancer. Nature, 482, 347-355.
https://doi.org/10.1038/nature10888
|
[21]
|
McLean, M.H. and El-Omar, E.M. (2014) Genetics of Gastric Cancer. Nature Reviews Gastroenterology & Hepatology, 11, 664-674. https://doi.org/10.1038/nrgastro.2014.143
|
[22]
|
Link, A., Schirrmeister, W., Langner, C., Varbanova, M., Bornschein, J., Wex, T. and Malfertheiner, P. (2015) Differential Expression of MicroRNAs in Preneoplastic Gastric Mucosa. Scientific Reports, 5, Article No. 8270.
https://doi.org/10.1038/srep08270
|
[23]
|
Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., Galas, D.J. and Wang, K. (2010) The MicroRNA Spectrum in 12 Body Fluids. Clin Chem, 56, 1733-1741. https://doi.org/10.1373/clinchem.2010.147405
|
[24]
|
Sousa, J.F., Nam, K.T., Petersen, C.P., Lee, H.J., Yang, H.K., Kim, W.H. and Goldenring, J.R. (2016) miR-30-HNF4γ and miR-194-NR2F2 Regulatory Networks Contribute to the Upregulation of Metaplasia Markers in the Stomach. Gut, 65, 914-924. https://doi.org/10.1136/gutjnl-2014-308759
|
[25]
|
Mishra, P.J. and Bertino, J.R. (2009) MicroRNA Polymorphisms: The Future of Pharmacogenomics, Molecular Epidemiology and Individualized Medicine. Pharmacogenomics, 10, 399-416. https://doi.org/10.2217/14622416.10.3.399
|
[26]
|
Liu, C., Rennie, W.A., Carmack, C.S., Kanoria, S., Cheng, J., Lu, J. and Ding, Y. (2014) Effects of Genetic Variations on MicroRNA: Target Interactions. Nucleic Acids Research, 42, 9543-9552. https://doi.org/10.1093/nar/gku675
|
[27]
|
Kupcinskas, J., Bruzaite, I., Juzenas, S., Gyvyte, U., Jonaitis, L., Kiudelis, G., Skieceviciene, J., Leja, M., Pauzas, H., Tamelis, A., Pavalkis, D. and Kupcinskas, L. (2014) Lack of Association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 Gene Polymorphisms and Colorectal Cancer. Scientific Reports, 4, Article No. 5993.
https://doi.org/10.1038/srep05993
|
[28]
|
Kupcinskas, J., Wex, T., Link, A., Leja, M., Bruzaite, I., Steponaitiene, R., Juzenas, S., Gyvyte, U., Ivanauskas, A., Ancans, G., Petrenkiene, V., Skieceviciene, J., Kupcinskas, L. and Malfertheiner, P. (2014) Gene Polymorphisms of MicroRNAs in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer. PLoS ONE, 9, e87467.
https://doi.org/10.1371/journal.pone.0087467
|
[29]
|
Fu, B., Song, P., Lu, M., Wang, B. and Zhao, Q. (2014) The Association between miR-146a Gene rs2910164 Polymorphism and Gastric Cancer Risk: A Meta-Analysis. Biomedicine & Pharmacotherapy, 68, 923-928.
https://doi.org/10.1016/j.biopha.2014.10.002
|
[30]
|
Liu, S., Dong, H., Dai, H., Liu, D. and Wang, Z. (2018) MicroRNA-216b Regulated Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting SOX9. Oncology Letters, 15, 10077-10083.
https://doi.org/10.3892/ol.2018.8573
|
[31]
|
Wang, W., Guo, Z., Yu, H. and Fan, L. (2019) Mir-216b Inhibits Os-teosarcoma Cell Proliferation, Migration, and Invasion by Targeting Forkhead Box M1. Journal of Cellular Biochemistry, 120, 5435-5443.
https://doi.org/10.1002/jcb.27822
|
[32]
|
Shao, Q., Zhang, P., Ma, Y., Lu, Z., Meng, J., Li, H., et al. (2018) Microrna-139-5p Affects Cisplatin Sensitivity in Human Nasopharyngeal Carcinoma Cells by Regulating the Epitheli-al-to-Mesenchymal Transition. Gene, 652, 48-58.
https://doi.org/10.1016/j.gene.2018.02.003
|
[33]
|
Pfeifer, G.P. (2018) Defining Driver DNA Methylation Changes in Human Cancer. International Journal of Molecular Sciences, 19, Article No. 1166.
|
[34]
|
Eyvazi, S., Khamaneh, A.M., Tarhriz, V., Bandehpour, M., Hejazi, M.S., Sadat, A.T.E. and Sepehri, B. (2019) CpG Islands Methylation Analysis of CDH11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients. Journal of Gastrointestinal Cancer, 51, 579-583. https://doi.org/10.1007/s12029-019-00290-1
|
[35]
|
Prabhu, A., Sarcar, B., Kahali, S., et al. (2014) Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth. Cancer Research, 74, 787-796. https://doi.org/10.1158/0008-5472.CAN-13-1423
|
[36]
|
Miki, K. and Urita, Y. (2007) Using Serum Pepsinogens Wisely in a Clinical Practice. Journal of Digestive Diseases, 8, 8-14. https://doi.org/10.1111/j.1443-9573.2007.00278.x
|
[37]
|
Pimanov, S.I., Makarenko, E.V., Voropaeva, A.V., Matveenko, M.E. and Voropaev, E.V. (2008) Helicobacter pylori Eradication Improves Gastric Histology and Decreases Serum Gastrin, Pepsinogen I and Pepsinogen II Levels in Patients with Duodenal Ulcer. Journal of Gastroenterology and Hepatology, 23, 1666-1671.
https://doi.org/10.1111/j.1440-1746.2007.04983.x
|
[38]
|
Nam, S.Y., Jeon, S.W., Lee, H.S., Kwon, Y.H., Park, H. and Choi, J.W. (2017) Long-Term Follow-Up of Pepsinogen I/II Ratio after Eradication of Helicobacter pylori in Pa-tients Who Underwent Endoscopic Mucosal Resection for Gastric Cancer. Digestive and Liver Disease, 49, 500-506. https://doi.org/10.1016/j.dld.2016.12.016
|
[39]
|
Cho, J.H., Jeon, S.R., Kim, H.G., Jin, S.Y. and Park, S. (2017) The Serum Pepsinogen Levels for Risk Assessment of Gastric Neoplasms: New Proposal from a Case-Control Study in Korea. Medicine, 96, e7603.
https://doi.org/10.1097/MD.0000000000007603
|
[40]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30.
https://doi.org/10.3322/caac.21442
|
[41]
|
Malfertheiner, P., Megraud, F., O’Morain, C.A., Gisbert, J.P., Kuipers, E.J., Axon, A.T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D.Y., Hunt, R., Moayyedi, P., Rokkas, T., Rugge, M., Selgrad, M., Suerbaum, S., Sugano, K. and El-Omar, E.M. (European Helicobacter and Microbiota Study Group and Consensus Panel) (2017) Management of Helicobacter pylori Infection: The Maastricht V/Florence Consensus Report. Gut, 66, 6-30.
https://doi.org/10.1136/gutjnl-2016-312288
|
[42]
|
Li, W., et al. (2014) Role of Exosomal Proteins in Cancer Di-agnosis. Gastric Cancer, 17, 26-33.
|
[43]
|
Ruivo, C.F., et al. (2017) The Biology of Cancer Exosomes: Insights and New Perspectives. Cancer Research, 77, 6480-6488. https://doi.org/10.1158/0008-5472.CAN-17-0994
|
[44]
|
Zhang, H., Deng, T., Liu, R., et al. (2017) Exosome-Delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis. Nature Communications, 8, Article ID: 15016. https://doi.org/10.1038/ncomms15016
|
[45]
|
Zhou, L., et al. (2017) The Biology, Function and Clinical Implications of Exosomes in Lung Cancer. Cancer Letters, 407, 84-92. https://doi.org/10.1016/j.canlet.2017.08.003
|